S'abonner

Respiratory syncytial virus infection of primary human mast cells induces the selective production of type I interferons, CXCL10, and CCL4 - 06/11/15

Doi : 10.1016/j.jaci.2015.01.042 
Ayham Al-Afif, MSc a, , Raidan Alyazidi, MD a, c, e, , Sharon A. Oldford, PhD a, Yan Y. Huang, PhD a, c, Christine A. King, PhD a, §, Nico Marr, PhD d, Ian D. Haidl, PhD a, Robert Anderson, PhD a, c, d, , , Jean S. Marshall, PhD a, b, ,
a Department of Microbiology and Immunology, Dalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada 
b Department of Pathology, Dalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada 
c Department of Pediatrics, Dalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada 
d Canadian Center for Vaccinology, Izaak Walter Killam Health Centre, Halifax, Nova Scotia, Canada 
e Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia 

Corresponding author: Jean S. Marshall, PhD, or Robert Anderson, PhD, Department of Microbiology and Immunology, Dalhousie University, 5850 College St, Halifax, Nova Scotia B3H 4R2, Canada.

Abstract

Background

Respiratory syncytial virus (RSV) causes severe respiratory tract infections, which might have a role in the development of airway hyperreactivity. Mast cells are important effector cells in allergy, with sentinel cell roles in host defense. However, the role of mast cells in response to RSV infection is unknown.

Objective

Human mast cell responses to RSV were investigated with a view to better understanding the role of mast cells in RSV-induced disease.

Methods

Human cord blood–derived mast cells and the HMC-1 mast cell line were exposed to RSV or UV-inactivated RSV. Viral gene and protein expression were evaluated by using PCR and flow cytometry. The expression of interferon-stimulated genes and selected mediators were evaluated by using quantitative PCR and ELISA.

Results

Human mast cells expressed multiple RSV genes after exposure to RSV, and a small percentage of mast cells supported RSV antigen protein expression. RSV induced mast cells to upregulate production of chemokines, including CCL4, CCL5, and CXCL10, as well as type I interferons, and interferon-stimulated gene expression. However, production of the granulocyte chemoattractants CXCL8 and CCL11 was not induced. Antibody blockade of the type I interferon receptor on human cord blood–derived mast cells reduced the RSV-mediated induction of CXCL10 and CCL4 but not CCL5. Leukotriene C4 production by mast cells was not enhanced by exposure to RSV.

Conclusion

Despite low levels of infection, human mast cells produce multiple chemokines in response to RSV through mechanisms that include responses to type I interferons. Such mast cell responses might enhance effector cell recruitment during RSV-induced disease.

Le texte complet de cet article est disponible en PDF.

Key words : Mast cells, viral infection, innate immunity, respiratory infection, chemokines, interferons, respiratory syncytial virus

Abbreviations used : CBMC, DC, ISG56, LTC4, MOI, MX1, NK, pDC, qPCR, RSV


Plan


 Supported by the Canadian Institutes of Health Research (CIHR) grant no. MOP10966. The CIHR had no role in the study design; the collection, analysis, and interpretation of data; or the writing and submission process for this manuscript.
 Disclosure of potential conflict of interest: This study was funded by the Canadian Institutes of Health Research (CIHR) grant no. MOP10966. S. A. Oldford has received support for travel to meetings for this study or other purposes from the CIHR, as has I. D. Haidl, and A. Al-Afif. J. S. Marshall is employed by Dalhousie University, which has received or has grants pending from the CIHR and AllerGen NCE. The rest of the authors declare that they have no relevant conflicts of interest.


© 2015  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 136 - N° 5

P. 1346 - novembre 2015 Retour au numéro
Article précédent Article précédent
  • Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)–associated inflammatory diseases
  • Dirk Holzinger, Selina Kathleen Fassl, Wilco de Jager, Peter Lohse, Ute F. Röhrig, Marco Gattorno, Alessia Omenetti, Sabrina Chiesa, Francesca Schena, Judith Austermann, Thomas Vogl, Douglas B. Kuhns, Steven M. Holland, Carlos Rodríguez-Gallego, Ricardo López-Almaraz, Juan I. Arostegui, Elena Colino, Rosa Roldan, Smaragdi Fessatou, Bertrand Isidor, Sylvaine Poignant, Koichi Ito, Hans-Joerg Epple, Jonathan A. Bernstein, Michael Jeng, Jennifer Frankovich, Geraldina Lionetti, Joseph A. Church, Peck Y. Ong, Mona LaPlant, Mario Abinun, Rod Skinner, Venetia Bigley, Ulrich J. Sachs, Claas Hinze, Esther Hoppenreijs, Jan Ehrchen, Dirk Foell, Jae Jin Chae, Amanda Ombrello, Ivona Aksentijevich, Cord Sunderkoetter, Johannes Roth
| Article suivant Article suivant
  • Dectin-1 activation unlocks IL12A expression and reveals the TH1 potency of neonatal dendritic cells
  • Sébastien Lemoine, Barbara Jaron, Sabrine Tabka, Chourouk Ettreiki, Edith Deriaud, Dania Zhivaki, Camille Le Ray, Odile Launay, Laleh Majlessi, Pierre Tissieres, Claude Leclerc, Richard Lo-Man

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.